U.S. Other Utilities Stock News

Event overview and recent share performance Charles River Laboratories International (CRL) has drawn investor attention after a period of weaker share performance, with the stock showing a 0.7% decline over the past day and a 2.4% decline over the past week. Those short term moves sit alongside a 5.2% decline over the past month and a 21.2% decline over the past 3 months. The shares are still up 40.0% over the past year and down 51.6% over 5 years. See our latest analysis for Charles River...

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...

Why Phibro Animal Health stock is on investors’ radar Recent trading in Phibro Animal Health (PAHC) has drawn attention, with the share price at $54.89 and total return data over the past month and past 3 months prompting closer scrutiny of the business fundamentals. See our latest analysis for Phibro Animal Health. That recent one day share price return of 3.22% sits on top of a 36.71% 90 day share price return and a very large 1 year total shareholder return, which suggests momentum has...

In late April 2026, semiconductor manufacturer IPG Photonics was caught in a broad sector selloff as concerns over future artificial intelligence spending and rising U.S.-China technology tensions weighed on investor sentiment and raised fears of supply chain disruption. The key takeaway is that IPG Photonics’ recent volatility appears tied more to macro and industry-wide semiconductor worries than to any company-specific operational change or new information about its core laser...

Recursion Pharmaceuticals recently confirmed it will report first-quarter 2026 results and business updates on May 6, 2026, with a publicly accessible earnings call allowing questions from investors and the broader community. At the same time, the company flagged leadership changes, including Chris Gibson, Ph.D., stepping down from the Board in June 2026 while remaining an advisor, underscoring an emphasis on continuity and its AI-driven drug discovery platform. We’ll examine how the...

T. Rowe Price Group (TROW) opened 2026 with Q1 revenue of US$1.9 billion and basic EPS of US$2.23, alongside trailing twelve month revenue of US$7.4 billion and EPS of US$9.34 that sit against modest 1.9% annual revenue growth and a 27.6% net profit margin over the past year. Over recent quarters, revenue has ranged from US$1.7 billion to US$1.9 billion, while quarterly EPS has moved between roughly US$1.93 and US$2.88. This provides a consistent picture of earnings power, even as the five...

Why EnerSys Is On Investors’ Radar Today EnerSys (ENS) has caught attention after a strong run over the past year, prompting investors to reassess what the current share price might already reflect about its business mix and fundamentals. See our latest analysis for EnerSys. Recent trading has been dominated by strong momentum, with a 19.4% 1 month share price return and 40.9% year to date share price return contributing to a 136.0% 1 year total shareholder return. This points to shifting...

Wondering if Cardinal Health at US$195.24 is still offering value after a strong multi year run? This article breaks down what the current price might be saying about the stock. The share price has eased recently, with a 2.3% decline over 7 days, a 7.9% decline over 30 days and a 5.1% decline year to date, even though the 1 year return stands at 32.0% and the 5 year return is 276.7%. Recent coverage around Cardinal Health has focused on its position in healthcare distribution and ongoing...

What recent returns suggest about C.H. Robinson Worldwide C.H. Robinson Worldwide (CHRW) has delivered mixed share price moves recently, with a 1 day return of 2.5% and a 7 day decline of 3.1%, while the past month shows a 5.2% gain. Over the past 3 months the stock shows a 9.1% decline, yet its 1 year total return of 98.9% and 5 year total return of 100.2% present a very different longer term picture for investors to weigh. See our latest analysis for C.H. Robinson Worldwide. At a share...

In April 2026, Kyndryl and Google Cloud expanded Kyndryl’s Distributed Cloud services to help enterprises modernize applications and deploy AI across hybrid, multicloud, and edge environments while addressing data sovereignty, regulatory, and performance needs. This move deepens Kyndryl’s role as an end-to-end cloud and IT services provider, positioning its experts at the center of Kubernetes-based modernization and AI workload deployment across complex infrastructures. Next, we’ll examine...

Smokey Bones, the barbecue chain originally founded by Darden Restaurants, has been fully closed after a 27 year run. The shutdown ends a long standing brand legacy that traces back to Darden’s earlier expansion in American casual dining. Although Darden no longer owns Smokey Bones, the closure adds context for investors tracking NYSE:DRI and the broader barbecue and casual dining space. Darden Restaurants, trading as NYSE:DRI, is coming off a mixed share performance backdrop, with the...

If you are wondering whether Kimco Realty's current share price lines up with its underlying value, this article walks through the key numbers so you can judge that for yourself. Over recent periods the stock has seen mixed returns, with a 1.3% decline over the last 7 days, a 4.1% gain over 30 days, 16.6% year to date, 16.0% over 1 year, 43.7% over 3 years and 35.3% over 5 years. Recent coverage of Kimco Realty has focused on its role as a large retail REIT and how investors are weighing...

Neurocrine Biosciences (NasdaqGS:NBIX) reported new two‑year Phase 3 data from its CAHtalyst Pediatric and Adult trials of CRENESSITY in classic congenital adrenal hyperplasia. The peer‑reviewed results cover both children and adults and highlight durable efficacy alongside physiologic glucocorticoid dosing. Data show sustained reductions in harmful steroid exposure and clinical improvements, including better body mass index and insulin resistance in pediatric patients. These findings...

In the lead-up to its 5 May 2026 earnings release, California Resources Corporation has been projected to post year-over-year declines in earnings and modestly lower revenues, even as Vanguard Portfolio Management disclosed a passive 5.94% ownership stake as of 31 March 2026. This combination of cautious profit expectations and increased institutional ownership highlights how investors are repositioning around California Resources’ evolving earnings profile and carbon-focused business...

BioNTech, NasdaqGS:BNTX, faces potential U.S. pharmaceutical tariffs that could affect access to a key market. The company is preparing for the announced departures of its co founders from leadership roles. These developments arrive while the share price stands at $97.54 and recent returns show mixed performance across different time frames. For investors watching NasdaqGS:BNTX, these leadership changes and tariff risks are landing on a share price of $97.54, with recent moves including a...

Semtech (SMTC) is back in focus after analysts highlighted its recent track record of exceeding earnings estimates and a current positive Earnings ESP, with supportive ratings indicating firm expectations for its upcoming results. See our latest analysis for Semtech. At a share price of $107.81, Semtech has seen a 30 day share price return of 34.7% and a year to date share price return of 43.25%. Its 1 year total shareholder return of 215.88% and 3 year total shareholder return of close to 5x...

Merchants Bancorp (MBIN) opened its latest earnings season update with first quarter results that highlighted higher net interest income of US$128.65 million and net income of US$67.73 million, along with basic EPS from continuing operations of US$1.25. See our latest analysis for Merchants Bancorp. The latest earnings update comes after a strong run, with the share price at US$46.60 and a year to date share price return of 40.45% alongside a 1 year total shareholder return of 50.56%. This...

CCC Intelligent Solutions Holdings launched mobile invoice scanning in the CCC ONE platform, integrating directly into its repair management workflow. The new feature uses AI to match invoice line items to repair orders, automating parts reconciliation for repair shops. The capability is available at no additional cost to users of CCC ONE, aiming to cut manual data entry and reduce processing time. CCC Intelligent Solutions Holdings, traded as NasdaqGS:CCC, is rolling out this product...

Alliance Resource Partners, L.P. recently reported first-quarter 2026 results showing revenue of US$516.02 million and net income of US$9.09 million, both lower than the same period a year earlier, while also affirming a quarterly cash distribution of US$0.60 per unit payable in May. Despite the sharp earnings drop, the partnership maintained its distribution and issued full-year 2026 coal sales volume guidance of 33.75 million to 35.25 million short tons, highlighting management’s focus on...

Itron, Inc. reported past first-quarter 2026 results with revenue of US$586.98 million and net income of US$53.46 million, while issuing second-quarter revenue guidance of US$560 million to US$570 million. The quarter underscored rapid growth in recurring revenue and meaningful contributions from the Resiliency Solutions segment, even as near-term guidance trailed analyst expectations. We’ll now examine how strong recurring revenue gains but softer near-term guidance may influence Itron’s...

Morgan Stanley recently downgraded e.l.f. Beauty, citing concerns about ongoing market share losses in its core U.S. cosmetics segment and the potential impact of planned price increases after summer 2025. At the same time, e.l.f. is investing in growth through acquisitions like rhode, international retail expansion and high-visibility partnerships in sports and entertainment, underscoring a push to broaden its brand beyond traditional cosmetics aisles. We’ll now examine how worries over...

Texas Instruments collaboration puts Lattice’s edge AI focus in the spotlight Lattice Semiconductor (LSCC) has drawn fresh attention after announcing a collaboration with Texas Instruments that links Lattice’s low power FPGA based Holoscan Sensor Bridge with TI sensing technologies for real time edge AI systems. See our latest analysis for Lattice Semiconductor. The Texas Instruments partnership arrives after a strong run in the stock, with a 30 day share price return of 27.3% and a 90 day...

If you are wondering whether Teradata is attractively priced or looking stretched at its current levels, you will want to understand what the valuation numbers are actually saying. The stock last closed at US$27.96, with returns of 5.8% over the past week, 10.8% over the past month, a 5.8% decline year to date, and 26.7% over the last year, alongside weaker 3 year and 5 year returns of 37.2% and 31.0% respectively. These mixed returns have kept Teradata on the radar for investors who pay...